Dr. Reddy's Laboratories Limited filings document its U.S. reporting as a foreign private issuer with American depositary receipts listed on the New York Stock Exchange. Recent Form 6-K reports furnish exchange intimations and exhibits submitted to Indian exchanges and the NYSE, including board-meeting notices and other current-report disclosures.
The filing record centers on Rule 13a-16 and 15d-16 submissions, Form 20-F reporting status, governance communications, and public-company notices tied to Dr. Reddy's pharmaceutical operations and securities across India and the United States.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.28%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.73%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.05%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.52%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.14%
Tags
-
Form 6-K
Rhea-AI Summary
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.47%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.47%
Tags
FAQ
How many DR REDDYS LABORATORIES (RDY) SEC filings are available on StockTitan?
StockTitan tracks 191 SEC filings for DR REDDYS LABORATORIES (RDY), including 20-F annual reports and 6-K reports. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for DR REDDYS LABORATORIES (RDY)?
The most recent SEC filing for DR REDDYS LABORATORIES (RDY) was filed on September 4, 2025.